Vor Biopharma Inc. (VOR)
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.
Address
100 CAMBRIDGEPARK DRIVE
CAMBRIDGE, MA 02140
Founded
2015
Number of Employees
168
Website
http://www.vorbio.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | - | $10 | - | - | $10 |
Average Price | - | - | - | - | - | - | - | - | $1.36 | - | - | $1.36 |
# Shares Purchased | - | - | - | - | - | - | - | - | 7,660 | - | - | 7,660 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | - | - | - | - | - | - | - | -26.5% | - | - | -26.5% |
S&P 500 Return to Date | - | - | - | - | - | - | - | - | 37.3% | - | - | 37.3% |
Excess Total Return | - | - | - | - | - | - | - | - | -63.7% | - | - | -63.7% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | - | - | - | - | - | - | - | 23% | - | - | 25% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)